{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:43:56Z","timestamp":1782747836241,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients seeking gender-affirming surgery are usually on hormone supplementation. We hypothesized that perioperative testosterone therapy increases hematoma following chest masculinizing surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Meta-analysis was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies with perioperative hormone status and surgical outcomes were included. Patient characteristics, testosterone use, surgical details, and outcomes were extracted. Meta-analysis and pooled analysis using aggregated patient-level data were conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Fifteen studies were included, comprising 3,036 testosterone-treatment (TT) and 726 non-testosterone-treatment (NTT) patients. Overall complication rates were similar (11.08% vs. 9.80%;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.29). Meta-analysis showed significantly higher hematoma in TT (OR 1.99, [1.19\u20133.34],\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001). Other complications showed no significant differences: infection (OR 0.33 [0.07\u20131.59]), wound dehiscence (OR 0.68 [0.04\u201311.06]), seroma (OR 0.5 [0.15\u20131.57]), and venous thromboembolism (OR 0.20 [0.0\u201310.42]). Hematoma risk did not differ between patients who continued versus stopped testosterone (TT-C 8.73% vs. TT-S 7.80%;\n                      <jats:italic>p<\/jats:italic>\n                      = 0.54), or by cessation timing (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.60). Mixed-effects meta-regression found incision type was not a significant moderator of hematoma (QM (1) = 0.34,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.56) among TT and NTT. Without stratifying by testosterone, hematoma rates were higher with limited incisions than extended incisions (11.96% vs. 6.5%;\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Testosterone therapy was associated with higher postoperative hematoma rates, while perioperative cessation did not reduce hematoma or overall complications. These findings support heightened perioperative awareness and vigilance for hematoma risk in patients receiving testosterone, while decisions regarding the timing of hormone therapy initiation should be carefully weighed against established mental health benefits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence III<\/jats:title>\n                    <jats:p>\n                      This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.springer.com\/00266\" ext-link-type=\"uri\">www.springer.com\/00266<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00266-026-05692-8","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:39:37Z","timestamp":1771947577000},"page":"4335-4347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Impact of Testosterone Supplementation on Surgical Complications in Gender-Affirming Mastectomy: A Meta-Analysis"],"prefix":"10.1007","volume":"50","author":[{"given":"Diwakar","family":"Phuyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe E.","family":"Belardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rampazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Bassiri Gharb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"8","key":"5692_CR1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.30348","volume":"6","author":"JD Wright","year":"2023","unstructured":"Wright JD, Chen L, Suzuki Y, Matsuo K, Hershman DL. National estimates of gender-affirming surgery in the US. JAMA Netw Open. 2023;6(8):e2330348.","journal-title":"JAMA Netw Open"},{"issue":"sup1","key":"5692_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","volume":"23","author":"E Coleman","year":"2022","unstructured":"Coleman E, Radix AE, Bouman WP, Brown GR, De Vries ALC, Deutsch MB, et al. Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgender Health. 2022;23(sup1):S1-259.","journal-title":"Int J Transgender Health."},{"issue":"6","key":"5692_CR3","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S2213-8587(16)00112-1","volume":"4","author":"CJD Wallis","year":"2016","unstructured":"Wallis CJD, Lo K, Lee Y, Krakowsky Y, Garbens A, Satkunasivam R, et al. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study. Lancet Diabetes Endocrinol. 2016;4(6):498\u2013506.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"5692_CR4","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/jamainternmed.2019.5135","volume":"180","author":"RF Walker","year":"2020","unstructured":"Walker RF, Zakai NA, MacLehose RF, Cowan LT, Adam TJ, Alonso A, et al. Association of testosterone therapy with risk of venous thromboembolism among men with and without hypogonadism. JAMA Intern Med. 2020;180(2):190.","journal-title":"JAMA Intern Med"},{"issue":"199","key":"5692_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.thromres.2020.12.029","volume":"1","author":"HT Ayele","year":"2021","unstructured":"Ayele HT, Brunetti VC, Renoux C, Tagalakis V, Filion KB. Testosterone replacement therapy and the risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trials. Thromb Res. 2021;1(199):123\u201331.","journal-title":"Thromb Res"},{"key":"5692_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00266-024-03931-4","author":"PD Huber","year":"2024","unstructured":"Huber PD, de Bittencourt RC, Jeziorowski A. Masculinizing mammoplasty for female-to-male transgenders: 10 years\u2019 experience. Aesthetic Plast Surg. 2024. https:\/\/doi.org\/10.1007\/s00266-024-03931-4.","journal-title":"Aesthetic Plast Surg"},{"issue":"3","key":"5692_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1177\/1076029613499819","volume":"20","author":"CJ Glueck","year":"2014","unstructured":"Glueck CJ, Richardson-Royer C, Schultz R, Burger T, Bowe D, Padda J, et al. Testosterone therapy, thrombophilia-hypofibrinolysis, and hospitalization for deep venous thrombosis-pulmonary embolus: an exploratory. Hypothesis-Generating Stud Clin Appl Thromb. 2014;20(3):244\u20139.","journal-title":"Hypothesis-Generating Stud. Clin Appl Thromb."},{"issue":"3","key":"5692_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/SAP.0000000000000882","volume":"78","author":"MJ Frederick","year":"2017","unstructured":"Frederick MJ, Berhanu AE, Bartlett R. Chest surgery in female to male transgender individuals. Ann Plast Surg. 2017;78(3):249.","journal-title":"Ann Plast Surg"},{"issue":"2","key":"5692_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/PRS.0000000000009858","volume":"151","author":"IS Robinson","year":"2023","unstructured":"Robinson IS, Rifkin WJ, Kloer C, Parker A, Blasdel G, Shakir N, et al. Perioperative hormone management in gender-affirming mastectomy: is stopping testosterone before top surgery really necessary? Plast Reconstr Surg. 2023;151(2):421.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"5692_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/SAP.0000000000002712","volume":"87","author":"KA Rothenberg","year":"2021","unstructured":"Rothenberg KA, Gologorsky RC, Hojilla JC, Tang A, Cohan C, Beattie G, et al. Gender-affirming mastectomy in transmasculine patients: does obesity increase complications or revisions? Ann Plast Surg. 2021;87(1):24\u201330.","journal-title":"Ann Plast Surg"},{"key":"5692_CR11","unstructured":"PRISMA Executive. PRISMA statement. 2024. Available from: https:\/\/www.prisma-statement.org."},{"issue":"91","key":"5692_CR12","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.bjps.2024.01.017","volume":"1","author":"Y Wolf","year":"2024","unstructured":"Wolf Y, Skorochod R, Elias S. Effect of testosterone replacement therapy on scar quality in gender-affirming mastectomies. J Plast Reconstr Aesthet Surg. 2024;1(91):360\u20132.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"81","key":"5692_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bjps.2022.11.057","volume":"1","author":"R Rysin","year":"2023","unstructured":"Rysin R, Skorochod R, Wolf Y. Implications of testosterone therapy on wound healing and operative outcomes of gender-affirming chest masculinization surgery. J Plast Reconstr Aesthet Surg. 2023;1(81):34\u201341.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"84","key":"5692_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bjps.2023.05.050","volume":"1","author":"R Skorochod","year":"2023","unstructured":"Skorochod R, Rysin R, Wolf Y. Gender affirming surgery in non-binary patients: the importance of patient-centered care. J Plast Reconstr Aesthet Surg. 2023;1(84):176\u201381.","journal-title":"J Plast Reconstr Aesthet Surg."},{"issue":"5","key":"5692_CR15","first-page":"441","volume":"73","author":"T Watanabe","year":"2019","unstructured":"Watanabe T, Sakurai T, Mukai Y, Kimata Y, Namba Y. Risk factors for postoperative hematoma after chest wall contouring for female-to-male transsexuals: a clinical study. Acta Med Okayama. 2019;73(5):441\u20137.","journal-title":"Acta Med Okayama"},{"issue":"3","key":"5692_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/SAP.0000000000001099","volume":"79","author":"DP Donato","year":"2017","unstructured":"Donato DP, Walzer NK, Rivera A, Wright L, Agarwal CA. Female-to-male chest reconstruction: a review of technique and outcomes. Ann Plast Surg. 2017;79(3):259.","journal-title":"Ann Plast Surg"},{"issue":"2","key":"5692_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1210\/endo.139.2.5683","volume":"139","author":"I Franck-Lissbrant","year":"1998","unstructured":"Franck-Lissbrant I, H\u00e4ggstr\u00f6m S, Damber JE, Bergh A. Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology. 1998;139(2):451\u20136.","journal-title":"Endocrinology"},{"issue":"1\u20133","key":"5692_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejphar.2012.03.032","volume":"684","author":"Y Chen","year":"2012","unstructured":"Chen Y, Fu L, Han Y, Teng Y, Sun J, Xie R, et al. Testosterone replacement therapy promotes angiogenesis after acute myocardial infarction by enhancing expression of cytokines HIF-1a, SDF-1a and VEGF. Eur J Pharmacol. 2012;684(1\u20133):116\u201324.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"5692_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1084\/jem.20091924","volume":"207","author":"DP Sieveking","year":"2010","unstructured":"Sieveking DP, Lim P, Chow RWY, Dunn LL, Bao S, McGrath KCY, et al. A sex-specific role for androgens in angiogenesis. J Exp Med. 2010;207(2):345\u201352.","journal-title":"J Exp Med"},{"issue":"239","key":"5692_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuroscience.2012.12.043","volume":"3","author":"Z Chen","year":"2013","unstructured":"Chen Z, Ye R, Goldman SA. Testosterone modulation of angiogenesis and neurogenesis in the adult songbird brain. Neuroscience. 2013;3(239):139\u201348.","journal-title":"Neuroscience"},{"issue":"3","key":"5692_CR21","doi-asserted-by":"publisher","first-page":"100272","DOI":"10.1016\/j.xgen.2023.100272","volume":"3","author":"F Raths","year":"2023","unstructured":"Raths F, Karimzadeh M, Ing N, Martinez A, Yang Y, Qu Y, et al. The molecular consequences of androgen activity in the human breast. Cell Genomics. 2023;3(3):100272.","journal-title":"Cell Genomics."},{"issue":"9","key":"5692_CR22","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1016\/j.bjps.2022.04.081","volume":"75","author":"JM Bekisz","year":"2022","unstructured":"Bekisz JM, Boyd CJ, Daar DA, Cripps CN, Bluebond-Langner R. Hematoma following gender-affirming mastectomy: a systematic review of the evidence. J Plast Reconstr Aesthet Surg. 2022;75(9):3108\u201321.","journal-title":"J Plast Reconstr Aesthet Surg."},{"issue":"3","key":"5692_CR23","first-page":"337","volume":"37","author":"J Winocour","year":"2017","unstructured":"Winocour J, Gupta V, Kaoutzanis C, Shi H, Shack RB, Grotting JC, et al. Venous thromboembolism in the cosmetic patient: Analysis of 129,007 patients. Aesthet Surg J. 2017;37(3):337\u201349.","journal-title":"Aesthet Surg J"},{"issue":"5","key":"5692_CR24","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0000000000010892","volume":"10","author":"WJ Rifkin","year":"2022","unstructured":"Rifkin WJ, Robinson IS, Kloer C, Cripps CN, Boyd CJ, Blasdel G, et al. Gender-affirming mastectomy: comparison of periareolar and double incision patterns. Plast Reconstr Surg. 2022;10(5):e4356.","journal-title":"Plast Reconstr Surg"},{"issue":"1","key":"5692_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11930-021-00322-7","volume":"14","author":"BN Goyette","year":"2022","unstructured":"Goyette BN, Hudnall MT, Halpern JA. Testosterone use in the perioperative setting. Curr Sex Health Rep. 2022;14(1):1\u20138.","journal-title":"Curr Sex Health Rep"},{"key":"5692_CR26","unstructured":"Kazzam ME, Ng P. Postoperative seroma management. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2025. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK585101\/."},{"key":"5692_CR27","doi-asserted-by":"publisher","first-page":"229255032513925","DOI":"10.1177\/22925503251392590","volume":"11","author":"S Sekhon","year":"2025","unstructured":"Sekhon S, Dinh V, Mitsakakis N, Cheung K. Patient preferences for postoperative drains following gender affirming mastectomy: a modified standard gamble approach. Plast Surg. 2025;11:22925503251392590.","journal-title":"Plast Surg"},{"issue":"1","key":"5692_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/asj\/sjx116","volume":"38","author":"G McEvenue","year":"2018","unstructured":"McEvenue G, Xu FZ, Cai R, McLean H. Female-to-male gender affirming top surgery: a single surgeon\u2019s 15-year retrospective review and treatment algorithm. Aesthet Surg J. 2018;38(1):49\u201357.","journal-title":"Aesthet Surg J"},{"issue":"9","key":"5692_CR29","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.18203\/2349-2902.isj20203768","volume":"7","author":"A Chaudhary","year":"2020","unstructured":"Chaudhary A, Gautam S. A prospective study of factors affecting seroma formation after modified radical mastectomy in patients of carcinoma of breast. Int Surg J. 2020;7(9):2919\u201324.","journal-title":"Int Surg J."},{"issue":"14","key":"5692_CR30","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.3390\/cancers15143606","volume":"15","author":"MB K\u00f6pke","year":"2023","unstructured":"K\u00f6pke MB, Wild CM, Schneider M, Pochert N, Schneider F, Sagasser J, et al. Elderly and patients with large breast volume have an increased risk of seroma formation after mastectomy\u2014results of the serma pilot study. Cancers. 2023;15(14):3606.","journal-title":"Cancers"},{"issue":"2","key":"5692_CR31","doi-asserted-by":"publisher","DOI":"10.4293\/JSLS.2023.00004","volume":"27","author":"NK Srivastava","year":"2023","unstructured":"Srivastava NK, Yadav AS, Sinha R. A comparative evaluation of extended total extraperitoneal repair versus standard total extraperitoneal repair and transabdominal preperitoneal repair of inguinal hernias. JSLS J Soc Laparoendosc Robot Surg. 2023;27(2):e2023.00004.","journal-title":"JSLS J Soc Laparoendosc Robot Surg"},{"issue":"6","key":"5692_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s10508-006-9104-9","volume":"35","author":"AA Lawrence","year":"2006","unstructured":"Lawrence AA. Patient-reported complications and functional outcomes of male-to-female sex reassignment surgery. Arch Sex Behav. 2006;35(6):717\u201327.","journal-title":"Arch Sex Behav"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-026-05692-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00266-026-05692-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-026-05692-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:45:03Z","timestamp":1782744303000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00266-026-05692-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["5692"],"URL":"https:\/\/doi.org\/10.1007\/s00266-026-05692-8","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"19 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}